FIELD: medicine.
SUBSTANCE: triterpenoid milyacin is used as a means for selective influence on biofilm formation by microorganisms, which reduces biofilm formation by pathogens - Salmonella typhimurium, Salmonella enteritidis and opportunistic Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus bacteria and at the same time preserves biofilm formation by normoflora - lactobacilli - Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus acidophilus and bifidobacteria - Bifidobacterium bifidum, Bifidobacterium adolescentis.
EFFECT: application of the invention provides a herbal remedy for effective prevention and treatment of infectious and pyoinflammatory diseases caused by biofilm-forming pathogenic and opportunistic bacteria.
9 dwg, 6 tbl, 1 ex
Authors
Dates
2018-03-05—Published
2016-04-25—Filed